Walgreens Mobilizes in Advance of Tropical Storm Barry to Support Customers, Team Members and Communities in Storm’s Projected Path

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens is taking proactive measures to assist customers, team members and communities currently in the projected path of Tropical Storm Barry, and is preparing to fully support any impacted regions in its aftermath. The company is taking the following steps: Prescription Drug Preparedness: In advance of the storm, Walgreens is underscoring the importance … [Read more…]

Global Aminoglycosides Market Analysis 2019-2024: Forecast by Product, Route of Administration, Application and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Aminoglycosides Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The global aminoglycosides market size is expected to witness a growth of over 4.3% CAGR over the forecast period, owing to the increasing burden of animal disease outbreaks leading to high utilization of antibiotics. Moreover, this … [Read more…]

The Global Primary Biliary Cholangitis Therapeutics Market Had a Significant Market Share in 2018 Which Is Expected to Continue During the Forecast Period, 2019-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Primary Biliary Cholangitis Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This will boost the sales of primary biliary cholangitis therapeutics and lead to the expansion of the global primary biliary cholangitis therapeutics market at a CAGR of close to 10% during the forecast period. Global Primary Biliary Cholangitis Therapeutics … [Read more…]

‘CURE® Expert Connections’ Launches ADT in Prostate Cancer: Managing Cardiovascular Risk Video Series

One patient and a physician expert discuss a variety of topics in prostate cancer CRANBURY, N.J.–(BUSINESS WIRE)–CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research — has unveiled a nine-episode discussion series featuring Andy Rochester, who shares his prostate … [Read more…]

Global Botulinum Toxin and HA Dermal Filler Market 2019-2023: Insights, Trends and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Botulinum Toxin and HA Dermal Filler Market Report: Insights, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The global botulinum toxin & HA dermal filler market is estimated to reach US$11.06 billion in 2023, growing at a CAGR of 7.52%, for the period spanning from 2018 to 2023. The … [Read more…]

Company Profile for Organigram Holdings Inc.

–(BUSINESS WIRE)–Organigram Holdings Inc. is a NASDAQ Global Select and TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships … [Read more…]

$20+ Billion Medicated Feed Additives Market – Global Outlook 2017-2018 & 2019-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Medicated Feed Additives – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. Global Medicated Feed Additives market accounted for $ 11,837.89 million in 2017 and is expected to reach $ 20,170.32 million by 2026 growing at a CAGR of 6.1% during the forecast period. The growing awareness about meat & … [Read more…]

The Global Polycystic Kidney Disease Drugs Market Set to Grow More Than 6%, 2019-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Polycystic Kidney Disease Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. Global Polycystic Kidney Disease Drugs Market: About this market The special regulatory designations will fuel the growth of the polycystic kidney disease drugs market at a CAGR of more than 6% during the forecast period. Polycystic kidney disease is … [Read more…]

cbdMD Interview to Air on Bloomberg International on the RedChip Money Report

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD) today announced an interview with Chairman & co-CEO Martin A. Sumichrast will air on The RedChip Money Report television program. The interview will air Sunday, July 14, on Bloomberg International, available in 149 million homes across Europe, the Middle East, and Africa. Check local listings for times in … [Read more…]

Gazyva (obinutuzumab; Roche/Biogen/Chugai/Nippon Shinyaku) Overview 2019: A Third-Generation, Type II Glycoengineered, Humanized Anti-CD20 Monoclonal Antibody (MAb) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gazyva” report has been added to ResearchAndMarkets.com’s offering. Gazyva (obinutuzumab; Roche/Biogen/Chugai/Nippon Shinyaku) is a third-generation, type II glycoengineered, humanized anti-CD20 monoclonal antibody (MAb) that recognizes the type II epitope of the CD20 antigen expressed on the surface of pre-B and mature-B lymphocytes. Gazyva mediates B-cell lysis through engagement of immune effector cells, by … [Read more…]